NanoViricides Inc. (NNVC)

[Echo20]

Reply from Dr Seymour:
2-1-2011

_____________________________________________________________
Dear Echo20

You will hear about EKC-Cide


It has not fallen between the cracks


Regarding your suggestion for money and a laboratory


In my estimation, we could could certainly solve the CMV issue but it's not about the money


It's about the people with specific skills that we need to be able to get the job done


My transplant surgeon friends desperately need drugs for influenza, adenovirus and CMV for their immunocompromised post-transplant patients


We'll eventually be there but now is the time to focus and get the first drug approved


Then there will be no shortage of scientists who would be willing to come to CT and work!


Sincerely,


EUGENE SEYMOUR, MD, MPH
Chief Executive Officer
NANOVIRICIDES, INC
Nanotechnology-based targeted anti-viral therapeutics

http://www.nanoviricides.com
[e-mail]
310-486-5677
____________________________________________________________

To me this points out a few items that seem to have been lacking in any explanation on NNVC and progress.

Special scientists are needed to complete the works!

EKC-Cide is still in the works.

Focusing on one drug.
A very clear email.


Echo20